{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:19:24Z","timestamp":1791271164467,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Genetics &amp; Development"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.gde.2009.03.008","type":"journal-article","created":{"date-parts":[[2009,5,5]],"date-time":"2009-05-05T05:07:56Z","timestamp":1241500076000},"page":"254-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":179,"title":["The genetics of Parkinson's syndromes: a critical review"],"prefix":"10.1016","volume":"19","author":[{"given":"John","family":"Hardy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Revesz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coro","family":"Paisan-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gde.2009.03.008_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuron.2006.09.016","article-title":"A hundred years of Alzheimer's disease research","volume":"52","author":"Hardy","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2009.03.008_bib2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"7","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.gde.2009.03.008_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.gde.2009.03.008_bib4","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1212\/WNL.54.5.1103","article-title":"Variant Alzheimer's disease with spastic paraparesis: clinical characterization","volume":"54","author":"Verkkoniemi","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.gde.2009.03.008_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/jhmas\/42.3.327","article-title":"The history of Alzheimer's disease: three debates","volume":"42","author":"Beach","year":"1987","journal-title":"J Hist Med Allied Sci"},{"key":"10.1016\/j.gde.2009.03.008_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.14.2.223","article-title":"An essay on the shaking palsy. 1817","volume":"14","author":"Parkinson","year":"2002","journal-title":"J Neuropsychiatr Clin Neurosci"},{"key":"10.1016\/j.gde.2009.03.008_bib7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/mds.10115","article-title":"Dopamine miracle: from brain homogenate to dopamine replacement","volume":"17","author":"Hornykiewicz","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.gde.2009.03.008_bib8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1001\/archneur.1993.00540020018011","article-title":"A clinicopathologic study of 100 cases of Parkinson's disease","volume":"50","author":"Hughes","year":"1993","journal-title":"Arch Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archneur.58.2.186","article-title":"Synucleinopathies: clinical and pathological implications","volume":"58","author":"Galvin","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib10","unstructured":"Guerreiro RJ, Baquero M, Blesa R, Boada M, Br\u00e1s JM, Bullido MJ, Calado A, Crook R, Ferreira C, Frank A, et al.: Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP. Neurobiol Aging. 2008, Jul 28, [Epub ahead of print]."},{"key":"10.1016\/j.gde.2009.03.008_bib11","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.gde.2009.03.008_bib12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.gde.2009.03.008_bib13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.gde.2009.03.008_bib14","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1212\/01.wnl.0000254458.17630.c5","article-title":"Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication","volume":"68","author":"Fuchs","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.gde.2009.03.008_bib15","doi-asserted-by":"crossref","first-page":"R123","DOI":"10.1093\/hmg\/ddh093","article-title":"The law of mass action applied to neurodegenerative disease: a hypothesis concerning the etiology and pathogenesis of complex diseases","volume":"13","author":"Singleton","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2009.03.008_bib16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib17","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ana.410430612","article-title":"Hereditary form of parkinsonism\u2013dementia","volume":"43","author":"Muenter","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib18","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/mds.21065","article-title":"Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered","volume":"21","author":"Braak","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.gde.2009.03.008_bib19_1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease","volume":"44","author":"Pais\u00e1n-Ru\u00edz","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2009.03.008_bib20","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/mds.21114","article-title":"Parkinson's disease due to the R1441G mutation in Dardarin: a founder effect in the Basques","volume":"21","author":"Sim\u00f3n-S\u00e1nchez","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.gde.2009.03.008_bib21","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1086\/429256","article-title":"Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations","volume":"76","author":"Kachergus","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gde.2009.03.008_bib22_1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJMc055509","article-title":"LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews","volume":"354","author":"Ozelius","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gde.2009.03.008_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10048-006-0041-5","article-title":"A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan","volume":"7","author":"Di Fonzo","year":"2006","journal-title":"Neurogenetics"},{"key":"10.1016\/j.gde.2009.03.008_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ana.21405","article-title":"Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease","volume":"64","author":"Ross","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"International LRRK2 Consortium. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case\u2013control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.nbd.2006.04.001","article-title":"Kinase activity is required for the toxic effects of mutant LRRK2\/dardarin","volume":"23","author":"Greggio","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.gde.2009.03.008_bib27","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.10113","article-title":"A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1","volume":"51","author":"Funayama","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib28_1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2009.03.008_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1212\/01.wnl.0000265059.56575.a6","article-title":"Reporting and interpretation of genetic variants in cases and controls","volume":"69","author":"Hardy","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.gde.2009.03.008_bib30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.gde.2009.03.008_bib31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1212\/WNL.47.1.160","article-title":"Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism","volume":"47","author":"Ishikawa","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.gde.2009.03.008_bib32","doi-asserted-by":"crossref","first-page":"P4","DOI":"10.1007\/PL00007745","article-title":"Clinical neuropathological aspects of autosomal recessive juvenile parkinsonism","volume":"245","author":"Ishikawa","year":"1998","journal-title":"J Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib33","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","article-title":"Association between early-onset Parkinson's disease and mutations in the parkin gene","volume":"342","author":"L\u00fccking","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gde.2009.03.008_bib34","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S1474-4422(07)70174-6","article-title":"Deciphering the role of heterozygous mutations in genes associated with parkinsonism","volume":"6","author":"Klein","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ana.1132","article-title":"Lewy bodies and parkinsonism in families with parkin mutations","volume":"50","author":"Farrer","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ana.20587","article-title":"Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers","volume":"58","author":"Pramstaller","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib37","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.gde.2009.03.008_bib38","doi-asserted-by":"crossref","first-page":"36588","DOI":"10.1074\/jbc.M304272200","article-title":"L166P mutant DJ-1, causative for recessive Parkinson's disease, is degraded through the ubiquitin-proteasome system","volume":"278","author":"Miller","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.gde.2009.03.008_bib39","doi-asserted-by":"crossref","first-page":"9103","DOI":"10.1073\/pnas.0402959101","article-title":"The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization","volume":"101","author":"Canet-Avil\u00e9s","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gde.2009.03.008_bib40","doi-asserted-by":"crossref","first-page":"10244","DOI":"10.1073\/pnas.0708518105","article-title":"RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways","volume":"105","author":"van der Brug","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gde.2009.03.008_bib41","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ana.20666","article-title":"DJ-1 mutations and parkinsonism\u2013dementia\u2013amyotrophic lateral sclerosis complex","volume":"58","author":"Annesi","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib42","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1212\/01.wnl.0000336651.48596.c7","article-title":"Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics?","volume":"71","author":"Verbaan","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.gde.2009.03.008_bib43","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson's disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.gde.2009.03.008_bib44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1212\/01.wnl.0000167546.39375.82","article-title":"Italian Parkinson Genetics Network. Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes","volume":"65","author":"Bonifati","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.gde.2009.03.008_bib45","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1001\/archneur.61.12.1898","article-title":"Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease","volume":"61","author":"Rogaeva","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib46","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/archneur.63.6.833","article-title":"Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit?","volume":"63","author":"Hedrich","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib47_1","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ana.20960","article-title":"A heterozygous effect for PINK1 mutations in Parkinson's disease?","volume":"60","author":"Abou-Sleiman","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib48","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/brain\/awl114","article-title":"PINK1 protein in normal human brain and Parkinson's disease","volume":"129","author":"Gandhi","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.gde.2009.03.008_bib49_1","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ng1884","article-title":"Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase","volume":"38","author":"Ramirez","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2009.03.008_bib50","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/mds.20511","article-title":"Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia","volume":"20","author":"Williams","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.gde.2009.03.008_bib51","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1600-0404.1994.tb02645.x","article-title":"Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome","volume":"89","author":"Najim al-Din","year":"1994","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.gde.2009.03.008_bib52_1","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.ajhg.2008.05.005","article-title":"Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500K SNP arrays","volume":"82","author":"Shojaee","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gde.2009.03.008_bib53","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1212\/01.wnl.0000338144.10967.2b","article-title":"FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome","volume":"72","author":"Di Fonzo","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.gde.2009.03.008_bib54","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4161\/cc.5.3.2403","article-title":"Fbxo7 gets proactive with cyclin D\/cdk6","volume":"5","author":"Laman","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.gde.2009.03.008_bib55","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of Gaucher disease","volume":"82","author":"Wong","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.gde.2009.03.008_bib56","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0888-7543(89)90319-4","article-title":"The human glucocerebrosidase gene and pseudogene: structure and evolution","volume":"4","author":"Horowitz","year":"1989","journal-title":"Genomics"},{"key":"10.1016\/j.gde.2009.03.008_bib57","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/bj3030377","article-title":"Analysis of glucocerebrosidase activity using N-(1-[14C]hexanoyl)-d-erythroglucosylsphingosine demonstrates a correlation between levels of residual enzyme activity and the type of Gaucher disease","volume":"303","author":"Meivar-Levy","year":"1994","journal-title":"Biochem J"},{"key":"10.1016\/j.gde.2009.03.008_bib58_1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jmg.2004.024455","article-title":"Parkinsonism among Gaucher disease carriers","volume":"41","author":"Goker-Alpan","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.gde.2009.03.008_bib59","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.wnl.0000276989.17578.02","article-title":"Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson's disease","volume":"69","author":"Clark","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.gde.2009.03.008_bib60","doi-asserted-by":"crossref","unstructured":"Neumann J, Bras J, Deas E, O'Sullivan SS, Parkkinen L, Lachmann RH, Li A, Holton J, Guerreiro R, Paudel R, et al.: Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain 2009, March 13, [Epub ahead of print].","DOI":"10.1093\/brain\/awp044"},{"key":"10.1016\/j.gde.2009.03.008_bib61","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/26652","article-title":"The ubiquitin pathway in Parkinson's disease","volume":"395","author":"Leroy","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.gde.2009.03.008_bib62","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ana.20757","article-title":"UCHL-1 is not a Parkinson's disease susceptibility gene","volume":"59","author":"Healy","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib63","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng1066","article-title":"Mutations in NR4A2 associated with familial Parkinson's disease","volume":"33","author":"Le","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2009.03.008_bib64","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/mds.21018","article-title":"NR4A2 genetic variation in sporadic Parkinson's disease: a genewide approach","volume":"21","author":"Healy","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.gde.2009.03.008_bib65","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/hmg\/ddi215","article-title":"Loss of function mutations in the gene encoding Omi\/HtrA2 in Parkinson's disease","volume":"14","author":"Strauss","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2009.03.008_bib66","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/hmg\/ddn096","article-title":"Sequencing analysis of OMI\/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls","volume":"17","author":"Sim\u00f3n-S\u00e1nchez","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2009.03.008_bib67","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO;2-X","article-title":"Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein\/apolipoprotein E genotype","volume":"45","author":"Kr\u00fcger","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib68","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1093\/hmg\/10.17.1847","article-title":"a-Synuclein gene haplotypes are associated with Parkinson's disease","volume":"10","author":"Farrer","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2009.03.008_bib69","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.20438","article-title":"Multiple regions of alpha-synuclein are associated with Parkinson's disease","volume":"57","author":"Mueller","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib70","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00439-003-1002-9","article-title":"Functional analysis of intra-allelic variation at NACP-Rep1 in the alpha-synuclein gene","volume":"113","author":"Chiba-Falek","year":"2003","journal-title":"Hum Genet"},{"key":"10.1016\/j.gde.2009.03.008_bib71","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/mds.1087","article-title":"The tau A0 allele in Parkinson's disease","volume":"16","author":"Golbe","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.gde.2009.03.008_bib72","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ana.410410222","article-title":"Genetic evidence for the involvement of tau in progressive supranuclear palsy","volume":"41","author":"Conrad","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib73","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/hmg\/8.4.711","article-title":"Association of an extended haplotype in the tau gene with progressive supranuclear palsy","volume":"4","author":"Baker","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2009.03.008_bib74","series-title":"Presented at the Annual Meeting of The American Society of Human Genetics, November 13","article-title":"Genome-wide association study in Parkinson's disease: identification of strong associations with SNCA and MAPT [Abstract program number 90]","author":"Scholz","year":"2008"},{"key":"10.1016\/j.gde.2009.03.008_bib75","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.277.5323.228","article-title":"Niemann\u2013Pick C1 disease gene: homology to mediators of cholesterol homeostasis","volume":"277","author":"Carstea","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.gde.2009.03.008_bib76","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1034\/j.1399-0004.2003.00147.x","article-title":"Niemann\u2013Pick disease type C","volume":"64","author":"Vanier","year":"2003","journal-title":"Clin Genet"},{"key":"10.1016\/j.gde.2009.03.008_bib77","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ymgme.2005.07.025","article-title":"Niemann\u2013Pick type C disease: novel NPC1 mutations and characterization of the concomitant acid sphingomyelinase deficiency","volume":"87","author":"Tamura","year":"2006","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.gde.2009.03.008_bib78","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/jnen\/63.4.323","article-title":"Aberrant phosphorylation of alpha-synuclein in human Niemann\u2013Pick type C1 disease","volume":"63","author":"Saito","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib79","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng572","article-title":"A novel pantothenate kinase gene (PANK2) is defective in Hallervorden\u2013Spatz syndrome","volume":"28","author":"Zhou","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2009.03.008_bib80","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/archneur.1974.00490310072012","article-title":"Hallervorden\u2013Spatz syndrome","volume":"30","author":"Dooling","year":"1974","journal-title":"Arch Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib81","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1212\/WNL.35.2.227","article-title":"Late-onset Hallervorden\u2013Spatz disease presenting as familial parkinsonism","volume":"35","author":"Jankovic","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.gde.2009.03.008_bib82","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1212\/WNL.51.3.887","article-title":"Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein","volume":"51","author":"Arawaka","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.gde.2009.03.008_bib83","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s004010000224","article-title":"Alpha-synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden\u2013Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies","volume":"100","author":"Neumann","year":"2000","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.gde.2009.03.008_bib84","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0002-9440(10)64548-8","article-title":"Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology","volume":"157","author":"Galvin","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.gde.2009.03.008_bib85","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ng1826","article-title":"PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron","volume":"38","author":"Morgan","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2009.03.008_bib86","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ana.21415","article-title":"Characterization of PLA2G6 as a locus for dystonia\u2013parkinsonism","volume":"65","author":"Paisan-Ruiz","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gde.2009.03.008_bib87","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/01.wnl.0000327094.67726.28","article-title":"Neurodegeneration associated with genetic defects in phospholipase A(2)","volume":"71","author":"Gregory","year":"2008","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.gde.2009.03.008_bib88","first-page":"20","article-title":"A pathological genotype\u2013phenotype study of four neuroaxonal dystrophy cases with PLA2G6 mutations","author":"Li","year":"2009","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.gde.2009.03.008_bib89_1","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nature04788","article-title":"Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin","volume":"441","author":"Park","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.gde.2009.03.008_bib90_1","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nature04779","article-title":"Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin","volume":"441","author":"Clark","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.gde.2009.03.008_bib91","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1111\/j.1742-4658.2008.06708.x","article-title":"Emerging pathways in genetic Parkinson's disease: autosomal-recessive genes in Parkinson's disease\u2014a common pathway?","volume":"275","author":"Fitzgerald","year":"2008","journal-title":"FEBS J"},{"key":"10.1016\/j.gde.2009.03.008_bib92","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0002-9440(10)65722-7","article-title":"Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes","volume":"153","author":"Lippa","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.gde.2009.03.008_bib93","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1111\/j.1742-4658.2008.06709.x","article-title":"Emerging pathways in genetic Parkinson's disease: potential role of ceramide metabolism in Lewy body disease","volume":"275","author":"Bras","year":"2008","journal-title":"FEBS J"},{"key":"10.1016\/j.gde.2009.03.008_bib94","doi-asserted-by":"crossref","DOI":"10.1038\/ng.300","article-title":"alpha-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity","author":"Gitler","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2009.03.008_bib95","doi-asserted-by":"crossref","first-page":"8251","DOI":"10.1021\/bi0502137","article-title":"Alpha-synuclein gene deletion decreases brain palmitate uptake and alters the palmitate metabolism in the absence of alpha-synuclein palmitate binding","volume":"44","author":"Golovko","year":"2005","journal-title":"Biochemistry"}],"container-title":["Current Opinion in Genetics &amp; Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X09000550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X09000550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:36:49Z","timestamp":1760701009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959437X09000550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":95,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0959437X09000550"],"URL":"https:\/\/doi.org\/10.1016\/j.gde.2009.03.008","relation":{},"ISSN":["0959-437X"],"issn-type":[{"value":"0959-437X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The genetics of Parkinson's syndromes: a critical review","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Genetics & Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gde.2009.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}